Benjamin J. Hindson, See Remarks at 10x Genomics, Inc. (TXG), sold 74,832 shares at $145.66 ($11.1M) on 2021-12-01, disclosed to the SEC on 2021-12-03.
Open-market sale of $11.1M TXG by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $145.66 | 5,400 | $787K | 7.1% |
| 2 | $146.53 | 5,369 | $787K | 7.1% |
| 3 | $146.53 | 5,369 | $787K | 7.1% |
| 4 | $147.65 | 13,561 | $2.0M | 18.1% |
| 5 | $147.65 | 13,561 | $2.0M | 18.1% |
| 6 | $148.42 | 7,571 |
| $1.1M |
| 10.1% |
| 7 | $148.42 | 7,571 | $1.1M | 10.1% |
| 8 | $149.46 | 4,849 | $725K | 6.5% |
| 9 | $149.46 | 4,849 | $725K | 6.5% |
| 10 | $150.66 | 1,816 | $274K | 2.5% |
| 11 | $150.66 | 1,816 | $274K | 2.5% |
| 12 | $151.46 | 2,100 | $318K | 2.9% |
| 13 | $152.25 | 100 | $15K | 0.1% |
| 14 | $153.91 | 700 | $108K | 1.0% |
| 15 | $155.55 | 200 | $31K | 0.3% |
| Total | $148.07 avg | 74,832 | $11.1M | 100% |
| Filing → |
| TXG | SELL | 2026-02-25 | $145K | — | Filing → |
| TXG | SELL | 2025-11-25 | $157K | — | Filing → |
| TXG | SELL | 2025-08-26 | $206K | — | Filing → |